Opes 15

A proprietary strategy designed to outperform

Opes 15 is an equally weighted portfolio of 15 carefully selected, elite large-cap stocks with strong growth potential. The selection is driven by our proprietary analysis and ranking system, which evaluates each company's profitability, growth outlook, and current fair value.

2001/1 to 2025/12	Return ^[1]	Annual return ^[2]
Opes 15	129 ×	22 %
S&P 500	8 ×	9 %
Dow Jones	8 ×	9 %
Nasdaq 100	14 ×	11 %
BRK-B ^[3]	10 ×	10 %

If you had invested $1,000 in an S&P 500 ETF on Jan 2, 2001, your investment would have grown to approximately $8,310 by Dec 9, 2025, representing a return multiple of 8.31 ×. Past performance is for illustrative purposes only and does not guarantee or imply future results.
Annual return refers to the annualized total return over the 25-year period from Jan 2, 2001, to Dec 9, 2025, calculated using the following formula: Annual return = (Return multiple) ^{(
¹⁄₂₅ )} - 1.
Berkshire Hathaway Inc., widely recognized as Warren Buffett's investment vehicle.

How Is the Opes 15 Portfolio Developed?

Built by Experienced Professionals

Opes 15 was designed by professionals with extensive experience in statistics, quantitative analysis, and equity research.
The strategy was rigorously researched and backtested using market data from January 2, 2001, to March 31, 2020. Performance after March 31, 2020 reflects live, real-world results, which to date have continued to outperform most major benchmarks.
To ensure reliability, we apply professional judgment and strict due diligence to avoid common backtesting pitfalls, including insufficient or biased data, arbitrary selection, statistical overfitting, and result manipulation.

Selection of the Top 15 Ranked Stocks (Equal-Weighted)

The portfolio consists of the 15 highest-ranked stocks, equally weighted to reduce concentration risk.
Candidates are filtered from the 1,000 largest U.S.-listed companies by market capitalization, ensuring a focus on large-cap, established firms rather than small-cap stocks. While primarily U.S.-based companies, the portfolio may occasionally include select Canadian or European firms listed in the U.S.
All selections are published based on independent equity research conducted by Opesway Inc., using objective statistical and financial analysis, without influence from subjective judgment, market hype, or promotional bias.

Check it out

How Is the Opes 15 Presented?

Monthly Updates and Disciplined Turnover

New stock selections are published at the beginning of each month.
The strategy has maintained an average monthly turnover rate of approximately 20%, typically replacing three stocks while retaining a total of 15 holdings.
New picks are released to subscribers before market open, ensuring fair access and preventing any preferential trading by our employees.

Full Transparency in Performance and Holdings

Complete performance data is available, including the results from 2001 to present, alongside comparisons with major benchmarks such as SPY, DIA, QQQ, and others.
Subscribers can view all historical and current portfolio holdings, with detailed insights into returns, risk metrics, and company profiles.

Subscribe now

Demo Video

Check the latest performance

Disclaimer

Opes 15 is generated using Opesway's proprietary statistical and financial models. The most up-to-date research reports are available to the public through a paid subscription. All content provided is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. The information presented is not tailored to the individual needs or circumstances of any investor.

Historical performance does not guarantee future results. The Opes 15 model may not accurately predict future market performance or investment outcomes. Before making any investment decisions based on this content, users should carefully evaluate their own financial situation, investment objectives, time horizon, risk preferences, and risk tolerance, or seek advice from a qualified financial professional to determine suitability.